HRP20050310A2 - Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors - Google Patents

Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors

Info

Publication number
HRP20050310A2
HRP20050310A2 HR20050310A HRP20050310A HRP20050310A2 HR P20050310 A2 HRP20050310 A2 HR P20050310A2 HR 20050310 A HR20050310 A HR 20050310A HR P20050310 A HRP20050310 A HR P20050310A HR P20050310 A2 HRP20050310 A2 HR P20050310A2
Authority
HR
Croatia
Prior art keywords
inhibitors
treatment
allergic rhinitis
selective phosphodiesterase
phosphodiesterase
Prior art date
Application number
HR20050310A
Other languages
English (en)
Inventor
Rundfeldt Chris
Kuss Hildegard
Höfgen Norbert
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of HRP20050310A2 publication Critical patent/HRP20050310A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20050310A 2002-09-06 2005-04-05 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors HRP20050310A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10241407A DE10241407A1 (de) 2002-09-06 2002-09-06 Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
PCT/EP2003/009895 WO2004022041A2 (de) 2002-09-06 2003-09-05 Behandlung nicht allergischer rhinitis durch selektive phosphodiesterase 4-hemmstoffe

Publications (1)

Publication Number Publication Date
HRP20050310A2 true HRP20050310A2 (en) 2005-06-30

Family

ID=31724458

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050310A HRP20050310A2 (en) 2002-09-06 2005-04-05 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors

Country Status (18)

Country Link
US (1) US20040116501A1 (no)
EP (1) EP1534272A2 (no)
JP (1) JP2005539058A (no)
KR (1) KR20050034760A (no)
CN (1) CN1678307A (no)
AR (1) AR041172A1 (no)
AU (1) AU2003271586A1 (no)
BR (1) BR0314031A (no)
CA (1) CA2497374A1 (no)
DE (1) DE10241407A1 (no)
HR (1) HRP20050310A2 (no)
MX (1) MXPA05002437A (no)
NO (1) NO20051468L (no)
PL (1) PL375494A1 (no)
RU (1) RU2005109939A (no)
TW (1) TW200404777A (no)
WO (1) WO2004022041A2 (no)
ZA (1) ZA200501582B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749999B2 (en) 2003-09-11 2010-07-06 Itherx Pharmaceuticals, Inc. Alpha-ketoamides and derivatives thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
DE19818964A1 (de) * 1998-04-28 1999-11-04 Dresden Arzneimittel Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань

Also Published As

Publication number Publication date
CA2497374A1 (en) 2004-03-18
ZA200501582B (en) 2005-09-09
KR20050034760A (ko) 2005-04-14
AU2003271586A1 (en) 2004-03-29
BR0314031A (pt) 2005-07-05
US20040116501A1 (en) 2004-06-17
NO20051468L (no) 2005-06-03
CN1678307A (zh) 2005-10-05
WO2004022041A3 (de) 2004-05-06
TW200404777A (en) 2004-04-01
PL375494A1 (en) 2005-11-28
AR041172A1 (es) 2005-05-04
EP1534272A2 (de) 2005-06-01
RU2005109939A (ru) 2005-09-10
WO2004022041A2 (de) 2004-03-18
MXPA05002437A (es) 2005-06-03
DE10241407A1 (de) 2004-03-18
JP2005539058A (ja) 2005-12-22

Similar Documents

Publication Publication Date Title
EP1511738A4 (en) TREATMENT OF FIBROPROLIFERATIVE DISEASES USING TGF BETA INHIBITORS
PL375981A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
ZA201207322B (en) Method of treatment of prophylaxis
AU2003239489A8 (en) Method of treating dyslipidemic disorders
IL175351A0 (en) Methods of treating asthma
IL164352A0 (en) Methods for treating tweak-related conditions
EP1799258A4 (en) METHODS FOR TREATMENT OF ANGIOGENESIS
PL378367A1 (pl) Sposób leczenia czynnościowych zaburzeń jelit
EP1626718A4 (en) METHOD FOR THE TREATMENT OF ISCHEMIC ILLNESSES
IL180675A0 (en) Methods of treating ccr2 mediated diseases or disorsers
EP1651237A4 (en) METHOD FOR THE TREATMENT OF DERMATOLOGICAL ILLNESSES
GB0306309D0 (en) Method of treatment
PL380068A1 (pl) Sposób obróbki szlamu
HRP20050310A2 (en) Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
GB0426196D0 (en) Methods of treatment
HK1080369A1 (zh) 用於治療多發性骨髓瘤的埃博霉素衍生物
GB0208897D0 (en) New method of treatment
GB0217493D0 (en) Novel methods of treatment
PL376796A1 (pl) Sposób wytwarzania inhibitorów fosfodiesterazy-4
GB0221712D0 (en) Methods of treatment
ZA200606071B (en) Methods of treating asthma
EP1494722A4 (en) THERAPEUTIC METHODS AGAINST INFLAMMATORY CONDITIONS RELATED TO EOTAXIN
GB0327975D0 (en) Methods of treatment
GB0213198D0 (en) Method of treatment
GB0207091D0 (en) Method of treatment

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20050824

Year of fee payment: 3

OBST Application withdrawn